ScoreWhy is Lincoln Pharmaceuticals Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 9.21% and Operating profit at 5.37% over the last 5 years
2
Flat results in Sep 25
- PAT(Q) At Rs 19.98 cr has Fallen at -24.1%
- ROCE(HY) Lowest at 15.46%
- PBT LESS OI(Q) At Rs 21.58 cr has Fallen at -12.98%
3
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
4
Below par performance in long term as well as near term
- Along with generating -46.39% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Lincoln Pharma. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Lincoln Pharma.
-46.39%
-1.19
39.05%
Sensex
4.78%
0.39
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.21%
EBIT Growth (5y)
5.37%
EBIT to Interest (avg)
52.34
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
1.00
Tax Ratio
26.68%
Dividend Payout Ratio
4.38%
Pledged Shares
0
Institutional Holding
4.73%
ROCE (avg)
22.49%
ROE (avg)
14.33%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
12
Industry P/E
34
Price to Book Value
1.39
EV to EBIT
8.86
EV to EBITDA
7.65
EV to Capital Employed
1.58
EV to Sales
1.21
PEG Ratio
NA
Dividend Yield
0.36%
ROCE (Latest)
17.79%
ROE (Latest)
11.18%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
OPERATING CF(Y)
Highest at Rs 93.02 Cr
-7What is not working for the Company
PAT(Q)
At Rs 19.98 cr has Fallen at -24.1%
ROCE(HY)
Lowest at 15.46%
PBT LESS OI(Q)
At Rs 21.58 cr has Fallen at -12.98%
Loading Valuation Snapshot...
Here's what is working for Lincoln Pharma.
Operating Cash Flow - Annually
Highest at Rs 93.02 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Here's what is not working for Lincoln Pharma.
Profit After Tax (PAT) - Quarterly
At Rs 19.98 cr has Fallen at -24.1%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 21.58 cr has Fallen at -12.98%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
